@ridgebackbio.com
Ridgeback Biotherapeutics develops potential medications to treat infectious diseases like Ebola and COVID-19.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
About
Description
Ridgeback Biotherapeutics is a leading brand in the field of biotechnology, specializing in the development of potential medications to combat infectious diseases such as Ebola and COVID-19. With a strong commitment to addressing the needs of patients suffering from diseases that have limited or no treatment options, Ridgeback Biotherapeutics is dedicated to making a significant impact on global health. The brand sets itself apart by investing resources and expertise in poorly-understood diseases early in the pharmaceutical development cycle.
By doing so, Ridgeback Biotherapeutics aims to tackle the challenges that arise when few stakeholders are prepared to make necessary commitments. The brand has been recognized for its groundbreaking work and has been featured in prestigious media outlets such as CNBC and The Wall Street Journal. Driven by their mission to innovate and accelerate life-changing and life-saving solutions, Ridgeback Biotherapeutics is devoted to improving the health and safety of the global population.
For inquiries or to learn more about their work, visit their website or reach out to them at their Miami-based address
Company Type
Privately Held
Company Size
11-50
Year Founded
2016
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories